LoHud | Ad Sales | Company

Morningstar® Investment Profileâ„¢

Â Â Â View: Â Â

Regeneron Pharmaceuticals, Inc.Â Â REGN

Data as of 11-20-2009 03:00 PM CT


Last Price	Day Change	Volume
$18.46	-0.21 (-1.12%)	347,653



Open Price	Day Range	52-Wk Range
$18.49	18.79 - 18.25	23.49 - 11.81



Mkt Cap($mil)	Yield	Avg Volume
1,486	0.00 %	755,551



P/E	P/S	P/CF
	4.34

Â Stock Chart

Â Key Stats


Morningstar Style Box	Small Growth	Stock Type	Speculative Growth
Industry	Biotechnology	Sector	Health Care
Market CapÂ $Mil	1,486	SalesÂ $Mil	338

Â Company Profile

What Does This Company Do?

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight inflammation, cancer, and eye disease. Its one marketed product, Arcalyst, which is approved to combat Cryopyrin-associated periodic syndromes, is also in late-stage testing for the treatment of gout. Additionally, Regeneron is developing aflibercept (partnered with Sanofi-Aventis) in a variety of cancer indications and VEGF trap (partnered with Bayer) for ophthalmologic diseases.

Address	777 Old Saw Mill River Road
Â	Tarrytown,Â NY,Â 10591-6707
Phone	1 914 347-7000
Website	http://www.regn.com
Employees	919
Direct Investment		No
Dividend Reinvestment		No

Quotes for Nasdaq securities are delayed 15 minutes. Quotes for NYSE and Amex securities are delayed 20 minutes, and are supplied by www.sdsmarketwatch.com. Graph Times are Eastern Standard. Copyright© 2008.

Show Data Definitions